Crystal structures of human 108V and 108M catechol O-methyltransferase

被引:109
作者
Rutherford, K. [1 ]
Le Trong, I. [2 ,3 ]
Stenkamp, R. E. [1 ,2 ,3 ]
Person, Vu. W. [1 ]
机构
[1] Univ Washington, Dept Biochem, Seattle, WA 98195 USA
[2] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA
[3] Univ Washington, Biomol Struct Ctr, Seattle, WA 98195 USA
关键词
catechol O-methyltransferase; single nucleotide polymorphism; Parkinson's disease; protein structure; crystallography;
D O I
10.1016/j.jmb.2008.04.040
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Catechol O-methyltransferase (COMT) plays important roles in the metabolism of catecholamine neurotransmitters and catechol estrogens. The development of COMT inhibitors for use in the treatment of Parkinson's disease has been aided by crystallographic structures of the rat enzyme. However, the human and rat proteins have significantly different substrate specificities. Additionally, human COMT contains a common valine-methionine polymorphism at position 108. The methionine protein is less stable than the valine polymorph, resulting in decreased enzyme activity and protein levels in vivo. Here we describe the crystal structures of the 108V and 108M variants of the soluble form of human COMT bound with S-adenosylmethionine (SAM) and a substrate analog, 3,5-dinitrocatechol. The polymorphic residue 108 is located in the alpha 5-beta 3 loop, buried in a hydrophobic pocket similar to 16 angstrom from the SAM-binding site. The 108V and 108M structures are very similar overall [RMSD of C-alpha atoms between two structures (C-alpha RMSD) = 0.2 angstrom], and the active-site residues are superposable, in accord with the observation that SAM stabilizes 108M COMT. However, the methionine side chain is packed more tightly within the polymorphic site and, consequently, interacts more closely with residues A22 (alpha 2) and R78 (alpha 4) than does valine. These interactions of the larger methionine result in a 0.7-angstrom displacement in the backbone structure near residue 108, which propagates along alpha 1 and alpha 5 toward the SAM-binding site. Although the overall secondary structures of the human and rat proteins are very similar (C-alpha RMSD=0.4 angstrom), several nonconserved residues are present in the SAM-(189M, 191M, C95Y) and catechol- (C173V, R201M, E202K) binding sites. The human protein also contains three additional solvent-exposed cysteine residues (C95, C173, C188) that may contribute to intermolecular disulfide bond formation and protein aggregation. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:120 / 130
页数:11
相关论文
共 87 条
[1]   CATECHOL O-METHYLTRANSFERASE PHARMACOGENETICS - PHOTOAFFINITY-LABELING AND WESTERN-BLOT-ANALYSIS OF HUMAN LIVER SAMPLES [J].
AKSOY, S ;
KLENER, J ;
WEINSHILBOUM, RM .
PHARMACOGENETICS, 1993, 3 (02) :116-122
[2]  
AXELROD J, 1958, J BIOL CHEM, V233, P702
[3]   Biochemical and molecular modeling studies of the O-methylation of various endogenous and exogenous catechol substrates catalyzed by recombinant human soluble and membrane-bound catechol-O-methyltransferases [J].
Bai, Hyoung-Woo ;
Shim, Joong-Youn ;
Yu, Jina ;
Zhu, Bao Ting .
CHEMICAL RESEARCH IN TOXICOLOGY, 2007, 20 (10) :1409-1425
[4]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[5]   HUMAN CATECHOL-O-METHYLTRANSFERASE - CLONING AND EXPRESSION OF THE MEMBRANE-ASSOCIATED FORM [J].
BERTOCCI, B ;
MIGGIANO, V ;
DAPRADA, M ;
DEMBIC, Z ;
LAHM, HW ;
MALHERBE, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (04) :1416-1420
[6]   Kinetics and crystal structure of catechol-O-methyltransferase complex with co-substrate and a novel inhibitor with potential therapeutic application [J].
Bonifácio, MJ ;
Archer, M ;
Rodrigues, ML ;
Matias, PM ;
Learmonth, DA ;
Carrondo, MA ;
Soares-da-Silva, P .
MOLECULAR PHARMACOLOGY, 2002, 62 (04) :795-805
[7]   HUMAN LIVER CATECHOL-O-METHYLTRANSFERASE PHARMACOGENETICS [J].
BOUDIKOVA, B ;
SZUMLANSKI, C ;
MAIDAK, B ;
WEINSHILBOUM, R .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 48 (04) :381-389
[8]   A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain [J].
Bray, NJ ;
Buckland, PR ;
Williams, NM ;
Williams, HJ ;
Norton, N ;
Owen, MJ ;
O'Donovan, MC .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (01) :152-161
[9]   ASSESSMENT OF PHASE ACCURACY BY CROSS VALIDATION - THE FREE R-VALUE - METHODS AND APPLICATIONS [J].
BRUNGER, AT .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1993, 49 :24-36
[10]   Functional analysis of genetic variation in catechol-o-methyltransferase (COMT):: Effects on mRNA, protein, and enzyme activity in postmortem human brain [J].
Chen, JS ;
Lipska, BK ;
Halim, N ;
Ma, QD ;
Matsumoto, M ;
Melhem, S ;
Kolachana, BS ;
Hyde, TM ;
Herman, MM ;
Apud, J ;
Egan, MF ;
Kleinman, JE ;
Weinberger, DR .
AMERICAN JOURNAL OF HUMAN GENETICS, 2004, 75 (05) :807-821